PEDIATRICS Vol. 75 No. 6 June 1985, pp. A62
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

JOHNSON & JOHNSON UNIT TO PAY $5.1 MILLION

Johnson & Johnson's Ortho Pharmaceutical Corp. unit has been ordered to pay $5.1 million to a woman who alleged that a widely used contraceptive gel caused her daughter to be born with severe birth defects. The product, Ortho-Gynol Contraceptive Jelly, is the most popular brand of a non-prescription spermicidal jelly, used by millions of women. Johnson & Johnson said the company planned to appeal the judge's ruling. "The overwhelming weight of scientific evidence is against the liklihood that the product could cause such a defect."